FDA Releases Guidance on Investigational Device Exemption Clinical Investigations

Summary

The Food and Drug Administration (FDA) has published a new guidance document to help sponsors, clinical investigators, and other stakeholders understand the regulatory implications of FDA's decisions on Investigational Device Exemption (IDE) clinical investigations, aimed at promoting the initiation of clinical trials to evaluate medical devices.